Peri-incisional Local Infiltration to Improve Pain Control After Periacetabular Osteotomy

Status: Recruiting
Location: See location...
Intervention Type: Combination product
Study Type: Interventional
Study Phase: Phase 2/Phase 3
SUMMARY

The goal of this clinical trial is to compare different peri-incisional local infiltrative anesthesia (PLIA) methods in patients ages 13 to 50 undergoing a periacetabular osteotomy (PAO). The main questions to answer here are: 1. Does PLIA impact post-operative pain after PAO? 2. Does PLIA impact pain medication usage as measured by morphine equivalent dosing (MED) after PAO? 3. Does the timing of PLIA administration impact post-operative pain and MED after PAO? Participants will be asked to complete some surveys; demographics survey, General Self-Efficacy Scale (GSE) and the Pain Resilience Scale. All other information will be gathered from the patients medical chart. Researchers will compare three groups. 1.) Patients who do not receive PLIA. 2.) Patients who receive PLIA after their incision is closed. 3.) Patients who receive PLIA throughout PAO.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 13
Maximum Age: 50
Healthy Volunteers: t
View:

• Adolescent or young adult diagnosed with hip dysplasia indicated for PAO at University of Iowa Hospital and Clinics.

Locations
United States
Iowa
University of Iowa Health Care
RECRUITING
Iowa City
Contact Information
Primary
Ashley S Kochuyt
ashley-kochuyt@uiowa.edu
319-384-5101
Time Frame
Start Date: 2024-10-03
Estimated Completion Date: 2026-09
Participants
Target number of participants: 120
Treatments
No_intervention: Control
No medication administration. Standard of care medications will be offered.
Active_comparator: Post Closure
Once the fascia has been closed, the PLIA will be administered using a pediatric catheter.
Active_comparator: Throughout Procedure
The injection will be performed throughout the surgical procedure.
Related Therapeutic Areas
Sponsors
Collaborators: Northwestern University
Leads: Michael C Willey

This content was sourced from clinicaltrials.gov